Selected Publications
Sriram Anbil, Nicholas Seewald, Elena G. Chiorean, Erika P. Hamilton, Maen Hussein, Pashtoon Kasi, Zulfiqar Malik, James A. Reeves, Gary K. Schwartz, Geoffrey Shapiro, Kevin K. Lin, Kenton Wride, Heidi Giordano, Lara Maloney, Karen McLachlan, Tanya Kwan, Hanna Tukachinsky, Alexa B Schrock, Shuogo Wang, Ethan S. Sokol, Brennan Decker, Katherine L. Nathanson, Susan M. Domchek, Kim A. Reiss: LODESTAR: A Single Arm Phase II Study of Rucaparib in Solid Tumors with Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes AACR Pancreas Meeting : 2024.
Ryan Hood, Srishti Rathore, Nicholas Seewald, Kim A. Reiss: Association of BRCA1/2 pathogenic variants with primary tumor location and metastatic organotropism in pancreatic adenocarcinoma ASCO 2024, Chicago, IL : 2024.
Bariq Jafry, Syed Kazmi, Kim A. Reiss, Salwan Al Mutar, Timothy Brown: Post-progression therapies and outcomes for patients with advanced, BRCA-related pancreatic cancer after receipt of PARP inhibitors: A national retrospective cohort study. ASCO 2024, Chicago, IL : 2024.
Sri Anbil, MD and Kim A. Reiss, MD: Targeting BRCA and PALB2 in Pancreatic Cancer Curr Treat Options Oncol : 2024.
Kim A. Reiss, MD; Mark H. O’Hara, MD; Ursina Teitelbaum, MD; Thomas B. Karasic, MD; Charles Schneider, MD; Caroline F. Pratz, CRNP; Katharine Nathanson, MD; Robert H. Vonderheide, MD, DPhil; Susan M. Domchek, MD: A phase II study of maintenance rucaparib in patients with platinum sensitive, advanced pancreatic cancer and a pathogenic germline or somatic variant in BRCA1, BRCA2 or PALB2: A four year survival update ASCO GI, San Francisco, CA : 2024.
Minh T. Than, Mark O’Hara, Ben Z. Stanger, Kim A. Reiss: KRAS-driven Tumorigenesis and KRAS-driven Therapy in Pancreatic Adenocarcinoma Molecular Cancer Therapeutics : 2024.
Erica Carpenter, Jacob Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon Pfeiffer, Jaclyn Lyman, Lacey Padron, Deena Maurer, Jia Xin Yu, Christine Spencer, Pier Gherardini, Diane Da Silva, Theresa LaVallee, charles Abbott, Richard Chen, Sean Michael Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Karasic, Charles Schneider, Peter O'Dwyer, Ursina Teitelbaum, Kim Reiss Binder, Osama Rahma, George Fisher, Andrew Ko, Zev Wainberg, Robert Wolff, Eileen O'Reilly, Mark O'Hara, Christopher Cabanski, and Robert Vonderheide: Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma Nature Communications : 2024.
Kelsey S. Lau-Min, MD, MSCE; Heather Symecko, MPH; Kelsey Spielman, MS, CGC; Ryan Hood, BA; Peter Gabriel, MD, MSE; Katharine A. Rendle, PhD, MPH; Katherine L. Nathanson, MD, 6; Kim A. Reiss, MD; Susan M. Domchek, MD: Integration of Germline Genetic Testing into Routine Clinical Practice for Patients with Pancreatic Adenocarcinoma JCO Precision Oncology : 2024.
Timothy J Brown, MD, Arielle Yablonovitch, PhD, Jacob E Till MD PhD, Jennifer Yen, PhD, Lesli A. Kiedrowski, MS MPH, Ryan Hood BA, Mark H. O’Hara MD, Ursina Teitelbaum MD, Thomas B. Karasic MD, Charles Schneider MD, Erica L. Carpenter, PhD MBA, Katherine Nathanson MD, Susan M. Domchek MD, and Kim A. Reiss MD: The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib Clin Cancer Res : 2023.
Ben Boursi, MD, MPH; Paul E. Wileyto, ScD; Ronac Mamtani, MD, MSCE; Susan M. Domchek, MD; Talia Golan, MD; Ryan Hood, BS; Kim A. Reiss, MD: Analysis of BRCA1 and BRCA2-Related Pancreatic Cancer and Survival JAMA Network Open : 2023.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-360-0735
Patient appointments: 800-789-7366